Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.85 NOK | 0.00% | -3.43% | -6.19% |
03-01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
Sales 2024 * | 57M 5.17M 414M | Sales 2025 * | 79M 7.17M 573M | Capitalization | 250M 22.67M 1.81B |
---|---|---|---|---|---|
Net income 2024 * | -30M -2.72M -218M | Net income 2025 * | -50M -4.54M -363M | EV / Sales 2024 * | 1.63 x |
Net cash position 2024 * | 157M 14.24M 1.14B | Net cash position 2025 * | 106M 9.61M 769M | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
-8.19
x | P/E ratio 2025 * |
-4.94
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.42% |
Latest transcript on Arctic Bioscience
1 week | -3.43% | ||
Current month | -1.30% | ||
1 month | +3.68% | ||
3 months | -6.19% | ||
6 months | +25.96% | ||
Current year | -6.19% |
Managers | Title | Age | Since |
---|---|---|---|
Hogne Hallaråker
FOU | Founder | 58 | 31/12/10 |
Chief Executive Officer | 52 | 28/02/22 | |
Jone R. Slinning
DFI | Director of Finance/CFO | 45 | 31/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 44 | 31/12/20 | |
Director/Board Member | 55 | 31/12/19 | |
Harald Nordal
FOU | Founder | 66 | 31/12/10 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 9.85 | 0.00% | 0 |
25/04/24 | 9.85 | 0.00% | 0 |
24/04/24 | 9.85 | 0.00% | 0 |
23/04/24 | 9.85 | -5.29% | 900 |
22/04/24 | 10.4 | +1.96% | 4,265 |
Real-time Oslo Bors, April 26, 2024 at 03:45 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.19% | 22.63M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ABS Stock